Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Albireo Pharma stock
Learn how to easily invest in Albireo Pharma stock.
Albireo Pharma is a biotechnology business based in the US. Albireo Pharma shares (ALBO) are listed on the NASDAQ and all prices are listed in US Dollars. Albireo Pharma employs 130 staff and has a trailing 12-month revenue of around $57.4 million.
How to buy Albireo Pharma stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ALBO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Albireo Pharma stock price (NASDAQ: ALBO)Use our graph to track the performance of ALBO stocks over time.
Albireo Pharma shares at a glance
|Latest market close||$44.59|
|52-week range||$16.02 - $44.75|
|50-day moving average||$28.12|
|200-day moving average||$23.82|
|Wall St. target price||$43.80|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-1.70|
Buy Albireo Pharma stocks from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Albireo Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Albireo Pharma price performance over time
|1 week (2023-01-31)||-0.16%|
|1 month (2023-01-06)||95.40%|
|3 months (2022-11-07)||99.24%|
|6 months (2022-08-05)||69.09%|
|1 year (2022-02-07)||43.84%|
|2 years (2021-02-05)||6.29%|
|3 years (2020-02-07)||95.74%|
|5 years (2018-02-06)||28.46%|
Albireo Pharma financials
|Revenue TTM||$57.4 million|
|Gross profit TTM||$39.2 million|
|Return on assets TTM||-24.94%|
|Return on equity TTM||-93.08%|
|Market capitalisation||$926.9 million|
TTM: trailing 12 months
Albireo Pharma share dividends
We're not expecting Albireo Pharma to pay a dividend over the next 12 months.
Have Albireo Pharma's shares ever split?
Albireo Pharma's shares were split on a 1:30 basis on 3 November 2016. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Albireo Pharma shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Albireo Pharma shares which in turn could have impacted Albireo Pharma's share price.
Albireo Pharma share price volatility
Over the last 12 months, Albireo Pharma's shares have ranged in value from as little as $16.02 up to $44.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Albireo Pharma's is 0.7119. This would suggest that Albireo Pharma's shares are less volatile than average (for this exchange).
Albireo Pharma overview
Albireo Pharma, Inc. , a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as well as in Phase III clinical trial for treating biliary atresia, alagille syndrome, and rare and life-threatening disorder to children; and Elobixibat for the treatment of chronic constipation and other functional diseases. It also engages in the developing of A3907, which is in Phase I clinical trial for the treatment of adult liver diseases; and A2342, a preclinical candidate to treat adult viral and liver diseases. The company has a license agreement with EA Pharma Co. , Ltd. for the development and commercialization of elobixibat.
Albireo Pharma in the news
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALBO, AJRD, CBIO, STAR
SHAREHOLDER ALERT: Morris Kandinov Investigating ALBO, APEN, ATCX and PAYA Mergers and Acquisitions; Shareholders are Encouraged to Contact the Firm
ALERT: The M&A Class Action Firm Continues Investigating the Merger – APEN, BRBW, ALBO, SAL
Frequently asked questionsWhat percentage of Albireo Pharma is owned by insiders or institutions?
Currently 3.505% of Albireo Pharma shares are held by insiders and 98.429% by institutions. How many people work for Albireo Pharma?
Latest data suggests 130 work at Albireo Pharma. When does the fiscal year end for Albireo Pharma?
Albireo Pharma's fiscal year ends in December. Where is Albireo Pharma based?
Albireo Pharma's address is: 10 Post Office Square, Boston, MA, United States, 02109 What is Albireo Pharma's ISIN number?
Albireo Pharma's international securities identification number is: US01345P1066 What is Albireo Pharma's CUSIP number?
Albireo Pharma's Committee on Uniform Securities Identification Procedures number is: 09064M105
More guides on Finder
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert